KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Current Leases (2016 - 2025)

Astrana Health's Current Leases history spans 10 years, with the latest figure at $7.2 million for Q3 2025.

  • For Q3 2025, Current Leases rose 1196.21% year-over-year to $7.2 million; the TTM value through Sep 2025 reached $7.2 million, up 1196.21%, while the annual FY2024 figure was $5.4 million, 728.17% up from the prior year.
  • Current Leases for Q3 2025 was $7.2 million at Astrana Health, up from $5.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $7.2 million in Q3 2025 and bottomed at $110000.0 in Q2 2021.
  • The 5-year median for Current Leases is $2.6 million (2021), against an average of $2.5 million.
  • The largest annual shift saw Current Leases plummeted 96.72% in 2021 before it skyrocketed 1196.21% in 2025.
  • A 5-year view of Current Leases shows it stood at $2.6 million in 2021, then soared by 35.87% to $3.6 million in 2022, then plummeted by 81.91% to $646000.0 in 2023, then soared by 728.17% to $5.4 million in 2024, then soared by 34.22% to $7.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Current Leases are $7.2 million (Q3 2025), $5.4 million (Q4 2024), and $554000.0 (Q3 2024).